Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection

被引:9
作者
Axtell, Andrea L. [1 ]
David, Elizabeth A. [2 ]
Block, Mark I. [3 ]
Parsons, Niharika [4 ]
Habib, Robert [4 ]
Muniappan, Ashok [1 ,5 ]
机构
[1] Massachusetts Gen Hosp, Div Thorac Surg, Boston, MA USA
[2] Univ Colorado Hosp, Sect Thorac Surg, Aurora, CO USA
[3] Mem Healthcare Syst, Div Thorac Surg, Hollywood, FL USA
[4] Soc Thorac Surg Res Ctr, Chicago, IL USA
[5] Massachusetts Gen Hosp, Div Thorac Surg, 55 Fruit St, Austen 7, Boston, MA 02114 USA
关键词
IDIOPATHIC PULMONARY-FIBROSIS; SURVIVAL; IMPACT; TERM; EXACERBATION; PREDICTORS; SURGERY; RISK;
D O I
10.1016/j.athoracsur.2023.04.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Prior studies have noted that patients with interstitial lung disease (ILD) possess an increased incidence of lung cancer and risk of postoperative respiratory failure and death. We sought to understand the impact of ILD on national-scale outcomes of lung resection.METHODS A retrospective cohort analysis using The Society of Thoracic Surgeons General Thoracic Surgery Database was conducted of patients who underwent a pulmonary resection for non-small cell lung cancer between 2009 and 2019. Baseline characteristics and postoperative outcomes were compared between patients with and without ILD (defined as interstitial fibrosis based on clinical, radiographic, or pathologic evidence). Multivariable logistic regression models identified risk factors associated with postoperative mortality, acute respiratory distress syndrome, and composite morbidity and mortality.RESULTS ILD was documented in 1.5% (1873 of 128,723) of patients who underwent a pulmonary resection for non-small cell lung cancer. Patients with ILD were more likely to smoke (90% vs 85%, P < .001), have pulmonary hypertension (6% vs 1.7%, P < .001), impaired diffusing capacity of lung for carbon monoxide (diffusing capacity of lung for carbon monoxide 40%-75%: 64% vs 51%; diffusing capacity of lung for carbon monoxide <40%: 11% vs 4%, P < .001), and undergo more sublobar resections (34% vs 23%, P < .001) compared with patients without ILD. Patients with ILD had increased postoperative mortality (5.1% vs 1.2%, P < .001), acute respiratory distress syndrome (1.9% vs 0.5%, P < .001), and composite morbidity and mortality (13.2% vs 7.4%, P < .001). ILD remained a strong predictor of mortality (odds ratio, 3.94; 95% CI, 3.09-5.01; P < .001), even when adjusted for patient comorbidities, pulmonary function, extent of resection, and center volume effects.CONCLUSIONS ILD is a risk factor for operative mortality and morbidity after lung cancer resection, even in patients with normal pulmonary function.
引用
收藏
页码:533 / 541
页数:9
相关论文
共 20 条
[1]   Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial [J].
Brown, Stacey-Ann Whittaker ;
Padilla, Maria ;
Mhango, Grace ;
Powell, Charles ;
Salvatore, Mary ;
Henschke, Claudia ;
Yankelevitz, David ;
Sigel, Keith ;
De-Torres, Juan P. ;
Wisnivesky, Juan .
CHEST, 2019, 156 (06) :1195-1203
[2]   Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review [J].
Chen, Hanbo ;
Senan, Suresh ;
Nossent, Esther J. ;
Boldt, R. Gabriel ;
Warner, Andrew ;
Palma, David A. ;
Louie, Alexander V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (03) :622-631
[3]   The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer [J].
Kenmotsu, Hirotsugu ;
Naito, Tateaki ;
Kimura, Madoka ;
Ono, Akira ;
Shukuya, Takehito ;
Nakamura, Yukiko ;
Tsuya, Asuka ;
Kaira, Kyoichi ;
Murakami, Haruyasu ;
Takahashi, Toshiaki ;
Endo, Masahiro ;
Yamamoto, Nobuyuki .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) :1242-1246
[4]   Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival [J].
Lee, Taehoon ;
Park, Ji Young ;
Lee, Hong Yeul ;
Cho, Young-Jae ;
Yoon, Ho Il ;
Lee, Jae Ho ;
Jheon, Sanghoon ;
Lee, Choon-Taek ;
Park, Jong Sun .
RESPIRATORY MEDICINE, 2014, 108 (10) :1549-1555
[5]   Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium [J].
Nathan, Steven D. ;
Shlobin, Oksana A. ;
Weir, Nargues ;
Ahmad, Shahzad ;
Kaldjob, Julienne M. ;
Battle, Edwinia ;
Sheridan, Michael J. ;
du Bois, Roland M. .
CHEST, 2011, 140 (01) :221-229
[6]   Predicting Severe Postoperative Complication in Patients With Lung Cancer and Interstitial Pneumonia [J].
Ohsawa, Manato ;
Tsutani, Yasuhiro ;
Fujiwara, Makoto ;
Mimae, Takahiro ;
Miyata, Yoshihiro ;
Okada, Morihito .
ANNALS OF THORACIC SURGERY, 2020, 109 (04) :1054-1060
[7]  
Okamoto Taku, 2004, Jpn J Thorac Cardiovasc Surg, V52, P323
[8]   Cumulative incidence of and predictive factors for lung cancer in IPF [J].
Ozawa, Yuichi ;
Suda, Takafumi ;
Naito, Tateaki ;
Enomoto, Noriyuki ;
Hashimoto, Dai ;
Fujisawa, Tomoyuki ;
Nakamura, Yutaro ;
Inui, Naoki ;
Nakamura, Hirotoshi ;
Chida, Kingo .
RESPIROLOGY, 2009, 14 (05) :723-728
[9]   Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial [J].
Palma, David A. ;
Chen, Hanbo ;
Bahig, Houda ;
Gaede, Stewart ;
Harrow, Stephen ;
Laba, Joanna M. ;
Qu, X. Melody ;
Rodrigues, George B. ;
Yaremko, Brian P. ;
Yu, Edward ;
Louie, Alexander, V ;
Dhaliwal, Inderdeep ;
Ryerson, Christopher J. .
BMC CANCER, 2019, 19 (01)
[10]   A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation- part 4: systematic review of evidence involving SBRT and ablation [J].
Park, Henry S. ;
Detterbeck, Frank C. ;
Madoff, David C. ;
Bade, Brett C. ;
Kumbasar, Ulas ;
Mase, Vincent J., Jr. ;
Li, Andrew X. ;
Blasberg, Justin D. ;
Woodard, Gavitt A. ;
Brandt, Whitney S. ;
Decker, Roy H. .
JOURNAL OF THORACIC DISEASE, 2022, 14 (06) :2412-+